Cannabis Bioscience International Holdings (CBIH) Interest Expenses (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Interest Expenses came in at $10776.0 in Q1 2026, down 52.05% year-on-year from $22473.0 in Q1 2025, and up 233.62% quarter-over-quarter from $3230.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Interest Expenses (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Interest Expenses across 5 years of filings, most recently posting $10776.0 for Q1 2026.
- Interest Expenses for Q1 2026 came in at $10776.0, down 52.05% year-over-year; the trailing twelve-month figure through Feb 2026 was $134123.0 (up 1031.99% YoY), and the FY2025 annual result was $136262.0, up 1138.75% from the prior year.
- Interest Expenses came in at $10776.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from $3230.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $102749.0 in Q2 2025 to a low of -$47904.0 in Q2 2024.
- The 5-year median for Interest Expenses is $10776.0 (2026), against an average of $19325.5.
- Across the five-year window, Interest Expenses plunged 4072.14% in 2024 and jumped 642.54% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Interest Expenses stood at $36278.0 in 2022, then tumbled by 86.2% to $5005.0 in 2023, then jumped by 73.85% to $8701.0 in 2024, then plunged by 62.88% to $3230.0 in 2025, then soared by 233.62% to $10776.0 in 2026.
- The last three Interest Expenses figures came in at $10776.0 (Q1 2026), $3230.0 (Q4 2025), and $17368.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | 10,776.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 10,776.00 |
| Feb 28, 2026 | 10,776.00 |
| Nov 30, 2025 | 3,230.00 |
| Nov 30, 2025 | 3,230.00 |
| Aug 31, 2025 | 17,368.00 |
| Aug 31, 2025 | 17,368.00 |
| May 31, 2025 | 102,749.00 |
| May 31, 2025 | 102,749.00 |
| Feb 28, 2025 | 22,473.00 |
| Feb 28, 2025 | 22,473.00 |
| Nov 30, 2024 | 8,701.00 |
| Nov 30, 2024 | 8,701.00 |
| Aug 31, 2024 | 2,339.00 |
| Aug 31, 2024 | 2,339.00 |
| May 31, 2024 | -47,904.00 |
| May 31, 2024 | -47,904.00 |
| Feb 29, 2024 | 49,221.00 |
| Feb 29, 2024 | 49,221.00 |
| Aug 31, 2023 | 5,005.00 |
| Aug 31, 2023 | 5,005.00 |